Journal of Shandong University (Health Sciences) ›› 2025, Vol. 63 ›› Issue (5): 101-110.doi: 10.6040/j.issn.1671-7554.0.2024.0531
• Public Health & Preventive Medicine • Previous Articles Next Articles
DU Xue1,2, LI Chunxia1,2, LIU Yunxia1,2, ZHANG Tao1,2
CLC Number:
| [1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. [2] Benson AB, Venook AP, Adam M, et al. Colon cancer, Version 3.2024, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2024, 22(2D): e240029. doi:10.6004/jnccn.2024.0029 [3] Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(10): 1139-1167. [4] 谢雅, 闫文锋, 夏晓博. 基于列线图模型预测结直肠癌淋巴结转移率与临床特征及预后的关系[J]. 癌症进展, 2023, 21(17): 1877-1880. XIE Ya, YAN Wenfeng, XIA Xiaobo. Correlation of metastatic lymph node ratio with clinical characteristics and prognosis in colorectal cancer predicted by nomogram model[J]. Oncology Progress, 2023, 21(17): 1877-1880. [5] 王廉源, 杨毅, 丛慧文, 等. 基于竞争风险模型的早发性结直肠癌患者预后影响因素分析[J]. 中国医科大学学报, 2023, 52(3): 199-205. WANG Lianyuan, YANG Yi, CONG Huiwen, et al. Ana-lysis of prognostic factors in patients with early-onset colo-rectal cancer based on a competitive risk model[J]. Journal of China Medical University, 2023, 52(3): 199-205. [6] 翟雅娜, 张敬东. 结直肠癌伴同时肝转移患者同期切除术后预后风险模型的创建及应用[J]. 现代肿瘤医学, 2020, 28(16): 2826-2832. ZHAI Yana, ZHANG Jingdong. Creation and application of prognostic risk model after simultaneous liver and colorectal resection for patients with synchronous colorectal liver metastasis[J]. Journal of Modern Oncology, 2020, 28(16): 2826-2832. [7] Zhang Q, Wang L, Sun RR, et al. Implications of pretreatment serum carcinoembryonic antigen levels and perineural invasion with staging, prognosis, and management in stage I-III colon cancer after surgery: a retrospective cohort study in the SEER database[J]. Ann Ital Chir, 2024, 95(2): 144-154. [8] Davis SE, Lasko TA, Chen GH, et al. Calibration drift in regression and machine learning models for acute kidney injury[J]. J Am Med Inform Assoc, 2017, 24(6): 1052-1061. [9] Kamada T, Ohdaira H, Takahashi J, et al. Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer[J]. Sci Rep, 2024, 14(1): 4192. doi:10.1038/s41598-024-54917-w [10] Ren GM, Li RK, Zheng GZ, et al. Prognostic value of normal levels of preoperative tumor markers in colorectal cancer[J]. Sci Rep, 2023, 13(1): 22830. doi:10.1038/s41598-023-49832-5 [11] Li ZH, Li CX, Pu HJ, et al. Trajectories of perioperative serum carcinoembryonic antigen and colorectal cancer outcome: a retrospective, multicenter longitudinal cohort study[J]. Clin Transl Med, 2021, 11(2): e293. doi:10.1002/ctm2.293 [12] You WQ, Yan L, Cai ZR, et al. Clinical significances of positive postoperative serum CEA and post-preoperative CEA increment in stage II and III colorectal cancer: a multicenter retrospective study[J]. Front Oncol, 2020, 10: 671. doi:10.3389/fonc.2020.00671 [13] Li ZH, Zhu HB, Pang XL, et al. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study[J].BMC Cancer, 2022, 22(1): 962. doi:10.1186/s12885-022-10051-2 [14] Zhu J, Hao J, Ma Q, et al.A novel prognostic model and practical nomogram for predicting the outcomes of colorectal cancer: based on tumor biomarkers and log odds of positive lymph node scheme[J]. Front Oncol, 2021, 11: 661040. doi:10.3389/fonc.2021.661040 [15] Kinnier CV, Asare EA, Mohanty S, et al. Risk prediction tools in surgical oncology[J]. J Surg Oncol, 2014, 110(5): 500-508. [16] Chang GJ, Hu CY, Eng C, et al. Practical application of a calculator for conditional survival in colon cancer[J]. J Clin Oncol, 2009, 27(35): 5938-5943. [17] Parr H, Porta N, Tree AC, et al. A personalized clinical dynamic prediction model to characterize prognosis for patients with localized prostate cancer: analysis of the CHHiP phase 3 trial[J]. Int J Radiat Oncol Biol Phys, 2023, 116(5): 1055-1068. [18] Wijnands AM, Penning de Vries BBL, Lutgens MWMD, et al. Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease[J]. Clin Gastroenterol Hepatol, 2024, 22(8): 1697-1708. [19] Li K, Luo S. Dynamic prediction of Alzheimers disease progression using features of multiple longitudinal outcomes and time-to-event data[J]. Stat Med, 2019, 38(24): 4804-4818. [20] Ren XH, Lin J, Stebbins GT, et al. Prognostic modeling of Parkinsons disease progression using early longitudinal patterns of change[J]. Mov Disord, 2021, 36(12): 2853-2861. [21] Happ C, Greven S. Multivariate functional principal component analysis for data observed on different(dimensional)domains[J]. J Am Stat Assoc, 2018, 113(522): 649-659. [22] Wichitaksorn N, Boris Choy ST, Gerlach R. A genera-lized class of skew distributions and associated robust quantile regression models[J]. Can J Statistics, 2014, 42(4): 579-596. [23] Sène M, Taylor JM, Dignam JJ, et al. Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: development and validation[J]. Stat Methods Med Res, 2016, 25(6): 2972-2991. [24] 李春霞. 结直肠癌围手术期血清肿瘤标志物轨迹分析及动态预测研究[D]. 济南: 山东大学, 2022. [25] Yao F, Müller HG, Wang JL. Functional data analysis for sparse longitudinal data[J]. J Am Stat Assoc, 2005, 100(470): 577-590. [26] Lyu Y, Liu Y, Xiao X, et al. High level of intraoperative lactate might predict acute kidney injury in aortic arch surgery via minimally invasive approach in patients with type A dissection[J]. Front Cardiovasc Med, 2023, 10: 1188393. doi:10.3389/fcvm.2023.1188393 [27] Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: users guides to the medical literature[J]. JAMA, 2017, 318(14): 1377-1384. [28] Happ C, Greven S. Multivariate functional principal component analysis for data observed on different(dimensional)domains[J]. J Am Stat Assoc, 2018, 113(522): 649-659. [29] Therneau TM. A package for survival analysis in R[EB/OL].(2023-03-12)[2024-05-01]. R package version 3.5-5, 2023. https://cran.r-project.org/web/packages/survival/vignettes/survival.pdf [30] Ushigome M, Shimada H, Miura Y, et al. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA[J]. Int J Clin Oncol, 2020, 25(4): 622-632. [31] Sonoda H, Yamada T, Matsuda A, et al. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer[J]. Eur J Surg Oncol, 2021, 47(11): 2880-2887. [32] Zhou SY, Sheng NQ, Ren JZ, et al. Clinical significance of and predictive risk factors for the postoperative elevation of carcinoembryonic antigen in patients with non-metastatic colorectal cancer[J]. Front Oncol, 2021, 11: 741309. doi:10.3389/fonc.2021.741309 [33] Lee JO, Kim M, Lee JH, et al. Carbohydrate antigen 19-9 plus carcinoembryonic antigen for prognosis in colorectal cancer: an observational study[J]. Colorectal Dis, 2023, 25(2): 272-281. [34] Proust-Lima C, Dartigues JF, Jacqmin-Gadda H. Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach[J]. Stat Med, 2016, 35(3): 382-398. [35] Elashoff RM, Li G, Li N. A joint model for longitudinal measurements and survival data in the presence of multiple failure types[J]. Biometrics, 2008, 64(3): 762-771. |
| [1] | LI Ziqi, WEI Yanruoxue, LIU Xiaohan, LIU Chuncheng, ZHAO Ran, LIU Yukun. The functional role and clinical significance of lncRNA HEATR3-AS1 in colorectal cancer tumorigenesis and progression [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 108-115. |
| [2] | LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74. |
| [3] | WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54. |
| [4] | JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99. |
| [5] | YANG Weifang, XU Hong, LIU Yuantao, ZHAO Huichen. Mechanism of thyroid-stimulating immunoglobulin in Graves disease recurrence and clinical significance [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 116-121. |
| [6] | WANG Gang, XU Pengyan, ZHAO Xuan, WANG Haifeng, GE Miaomiao, PAN Huafeng, JIANG Zhiwei. Effect of ω-3 polyunsaturated fatty acids on recovery of autonomic nervous system and intestinal function after laparoscopic colorectal cancer surgery [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 36-42. |
| [7] | CUI Qianqian, LI Jinpeng, WU Yudan, HOU Zhiping, SUN Weiluo, CUI Panpan, HE Peiyuan. Clinical value of fecal miRNA for non-invasive screening of advanced colorectal adenomas [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 43-50. |
| [8] | CHANG Yu, HU Yunfeng, WANG Huifeng, GUO Jing, ZHANG Tiao, HAO Yaqin, LIU Yu. A mendelian randomization study on the association between appendectomy and the risk of colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 77-83. |
| [9] | YU Jing, WANG Gang, WANG Ye, SHAO Mingyue, PAN Huafeng, GE Miaomiao, WANG Haifeng, JIANG Zhiwei. Effect of Yiqidaozhi Decoction in postoperative intestinal recovery of colorectal cancer patients based on I-FEED scoring system [J]. Journal of Shandong University (Health Sciences), 2025, 63(12): 35-43. |
| [10] | LIU Wenzhao, ZHANG Yuan, MA Xiangping, WEI Fengtao, BU Peili. Correlation between the pre-endothelial activation and stress index and the mortality risk of patients with heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 27-35. |
| [11] | CHEN Wenliang, WANG Huanhuan, HAO Jinjin, GONG Rui, ZHAO Qiang, ZHANG Fei, GAO Lei, DONG Jingxun. The role of lncRNA PVT1 in prognostic assessment and malignant progression of gastric cancer: a study based on nomogram model and functional cellular experiments [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 61-71. |
| [12] | GUO Shuhua, FAN Yang, TIAN Feng, WANG Chuanxin, DU Lutao, LI Peilong, GUO Xing, XU Shuo. Role of microfibril-associated protein 3 in regulating mesenchymal transition of glioma stem cells [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 9-16. |
| [13] | WANG Xiao, KONG Wenru, CUI Weiliang, WANG Shuqi. Alstonia mairei total alkaloids enhance the sensitivity of colorectal cancer to 5-fluorouracil chemotherapy [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 30-37. |
| [14] | WEI Yanruoxue, LI Ziqi, LIU Chuncheng, LIU Xiaohan, ZHAO Ran, LIU Yukun. Intratumor heterogeneity of SP1 expression in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 89-94. |
| [15] | LIU Chuncheng, LIU Xiaohan, WEI Yanruoxue, LI Ziqi, LIU Yukun, ZHAO Ran. Subcellular localization pattern of bromodomain containing 9 in colorectal cancer and its clinical significance [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 24-30. |
|
||